Australia's most trusted
source of pharma news
Sunday, 05 October 2025
Posted 1 October 2025 AM
Two new faces will lead Medicines Australia's Oncology Industry Taskforce (OIT) with AstraZeneca's Heather Cahill and GSK's Katrina Vanin stepping down from the role of Co-Chairs after two years.
The baton has been passed to Lilly's Jeremy Fowke and Menarini Stemline's Vanessa Van Den Berg. Fowke took up the role of Oncology and Immunology Business Unit Leader ANZ in July. Van Den Berg started at Menarini as Head of Oncology, Access and Medical Strategy in May.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.